Procalcitonin as a Diagnostic Marker in Patients with Infectious Diseases
Keigo Ashitani,Takehito Kobayashi,Kohei Saito,Rie Shiomi,Kazuya Miyaguchi,Akira Yokoyama,Ryutaro Aoyagi,Toru Noguchi,Minoru Yamaoka,Shin-ichiro Iida,Yoshikazu Tsuzuki,Nobutaka Hirooka,Masayoshi Hashimoto,Yoshitaka Miyakawa,Hiroyuki Imaeda,Keiji Yamamoto,Hidetomo Nakamoto
DOI: https://doi.org/10.21203/rs.3.rs-1049972/v1
2021-11-30
Abstract:Abstract Background: Procalcitonin levels have been shown to indicate severity of a disease, but there have been few reports about interpretation of procalcitonin levels between different diseases. This study was therefore carried out to investigate the usefulness of procalcitonin for clinical diagnosis, and for discriminating between bacterial and viral infection, between cystitis and pyelonephritis, and between acute upper respiratory inflammation and pneumonia. Methods: Among patients with the primary complaint of fever who were treated, either hospitalized or as out-patients, at Saitama Medical University Hospital during a 5-year period from August 1, 2012, to July 31, 2017, the potential subjects for this study were the 362 patients, consisting of 191 males and 171 females, with whom procalcitonin was measured. The subjects with whom comparative evaluation was carried out were the 205 with whom the final diagnoses were diseases, these being infectious diseases, malignancies, collagen diseases, and benign tumors with 176, 12, 11 and 6 patients, respectively. The remaining patients were excluded from the study, these consisting of 150 patients with whom the final diagnosis was merely symptoms such as headache, or was a condition not covered by internal medicine, such as traumas; and 7 patients whose diagnoses were unknown. Results: Procalcitonin levels in patients with infectious diseases were significantly higher (p < 0.05) than in patients with malignant tumors, collagen diseases, or benign tumors. Comparison between different diseases showed significant differences (p < 0.05) between pyelonephritis and cystitis, and between bacterial pneumonia and acute upper respiratory inflammation. Conclusions: Procalcitonin was significantly elevated in patients with bacterial infection. Significant differences in procalcitonin level were found between pyelonephritis and cystitis, and between bacterial pneumonia and acute upper respiratory inflammation, so procalcitonin is considered to be useful for discrimination between these.